DUBLIN--(BUSINESS WIRE)--The "Drafting and Managing Pharmaceutical Safety Data Exchange Agreements" conference has been added to Research and Markets' offering.
The effective management of the pharmacovigilance aspects of commercial agreements is essential for all parties involved. Ensuring the inclusion of key pharmacovigilance-relevant terms in agreements and monitoring compliance with them can be challenging, but is essential for compliance with current regulatory requirements relating to medicinal products.
This interactive seminar will address the key regulatory requirements relating to pharmacovigilance and discuss how to ensure that they are taken into account in various types of commercial arrangements. The emphasis will be on identifying the key terms needed in different types of agreement with a view to ensuring regulatory compliance and on a practical approach to drafting.
The seminar will be of interest to personnel involved in negotiating, preparing and managing commercial agreements of various types (for example, between co-marketers and with distributors, vendors and service providers) where the inclusion of pharmacovigilance terms and obligations is needed, including those working in safety, commercial, regulatory affairs and legal departments.
For more information about this conference visit https://www.researchandmarkets.com/research/hzfzqk/drafting_and